APA (7th ed.) Citation

E, C., F, S., C, S. L. G., A, B., V, N., D, B., . . . JA, A. M. (2024). C-Peptide and BMi predict anti-hyperglycemic treatment lines in breast cancer patients treated with Alpelisib. Endocrine, 86(2), 470. https://doi.org/10.1007/s12020-024-03924-y

Chicago Style (17th ed.) Citation

E, Carrillo-Lopez, Sebastian-Valles F, Sager La Ganga C, Ballesteros A, Navas-Moreno V, Bañón D, López Martí MP, Marazuela M, and Arranz Martín JA. "C-Peptide and BMi Predict Anti-hyperglycemic Treatment Lines in Breast Cancer Patients Treated with Alpelisib." Endocrine 86, no. 2 (2024): 470. https://doi.org/10.1007/s12020-024-03924-y.

MLA (9th ed.) Citation

E, Carrillo-Lopez, et al. "C-Peptide and BMi Predict Anti-hyperglycemic Treatment Lines in Breast Cancer Patients Treated with Alpelisib." Endocrine, vol. 86, no. 2, 2024, p. 470, https://doi.org/10.1007/s12020-024-03924-y.